Skip to content

Clinical trials

Recruiting Phase 1/2 Melanoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 1/2 Status: Recruiting Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20131
20151
20171
20195
20203
20216
20227
202313
202413
202511
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting74

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hadassah Medical Organization3
Essen Biotech2
GV20 Therapeutics2
Iovance Biotherapeutics, Inc.2
National Cancer Institute (NCI)2
Strand Therapeutics Inc.2
The Netherlands Cancer Institute2
7 Hills Pharma, LLC1
Aminex Therapeutics, Inc.1
Arvinas Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma74
Carcinoma, Non-Small-Cell Lung28
Colorectal Neoplasms15
Neoplasm Metastasis15
Carcinoma, Renal Cell14
Neoplasms14
Squamous Cell Carcinoma of Head and Neck14
Ovarian Neoplasms13
Stomach Neoplasms12
Uterine Cervical Neoplasms10

Trials

Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.